SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-038009
Filing Date
2024-03-28
Accepted
2024-03-28 16:01:38
Documents
81
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K rphm-20231231.htm   iXBRL 10-K 2238927
2 EX-21.1 rphm-ex21_1.htm EX-21.1 5263
3 EX-23.1 rphm-ex23_1.htm EX-23.1 6875
4 EX-26.1 rphm-ex26_1.htm EX-26.1 12747
5 EX-31.1 rphm-ex31_1.htm EX-31.1 17109
6 EX-31.2 rphm-ex31_2.htm EX-31.2 18040
7 EX-32.1 rphm-ex32_1.htm EX-32.1 15859
8 EX-97.1 rphm-ex97_1.htm EX-97.1 48265
9 GRAPHIC img27553928_0.jpg GRAPHIC 10172
  Complete submission text file 0000950170-24-038009.txt   8324833

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rphm-20231231.xsd EX-101.SCH 1141306
84 EXTRACTED XBRL INSTANCE DOCUMENT rphm-20231231_htm.xml XML 1323330
Mailing Address 18575 JAMBOREE ROAD SUITE 275-S IRVINE CA 92612
Business Address 18575 JAMBOREE ROAD SUITE 275-S IRVINE CA 92612 (858) 283-0280
Reneo Pharmaceuticals, Inc. (Filer) CIK: 0001637715 (see all company filings)

IRS No.: 472309515 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-40315 | Film No.: 24798690
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)